MedPath

Diagnostic of Iron Deficiency by Means of Non Invasive Measurement of Zink Protoporphyrin IX

Completed
Conditions
Iron-deficiency
Registration Number
NCT03231865
Lead Sponsor
Philipp Stein
Brief Summary

ZnPP is being build in the case of a functional iron deficiency. Zinc instead of iron is implemented into protoporphyrin IX. This ZincProtoporphyrin (ZnPP) can be detected non invasively. Non invasive and invasive optical measurement of ZnPP will be compared. Additionally ZnPP measurements will be compared to other iron deficiency parameters for validation by the investigators.

Detailed Description

Zinc-protoporphyrin (ZnPP) will be measured by a fluorescence technique. Restricted wave light (407/425 nm) is used to detect ZnPP in the bloodstream non-invasively through the oral mucosa. The spectroscopic measurements are translated into a ZnPP value (mumol/mol heme).

The non-invasive measurement of ZnPP is validated and compared to optical measurement of ZnPP in whole blood and high performance liquid chromatography (HPLC) measurement of ZnPP in whole blood.

The ZnPP value is compared to other iron-deficiency parameters: Ferritin, Transferrin saturation and soluble Transferrin receptor.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Patients seen preoperatively in the Anesthestic clinic
  • Patients > 18 years of age
  • Understood and signed patient consent
Exclusion Criteria
  • transfusion of blood products 8 weeks prior to screening
  • Pregnancy
  • Porphyria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Validation of the non-invasive ZincProtoporphyrinIX measurementBaseline

The value is compared to optical measurement of ZincProtoporphyrin in whole blood; in addition the value is compared to HPLC measurement in whole blood

Secondary Outcome Measures
NameTimeMethod
Comparison of the ZincProtoporyphyrinIX value to other iron-deficiency parametersBaseline

The value is compared to Ferritin, Transferrin saturation and soluble transferrin receptor

Trial Locations

Locations (1)

University Hospital Zurich

🇨🇭

Zurich, Switzerland

University Hospital Zurich
🇨🇭Zurich, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.